Vaxart, Inc. (VXRT) News
Follow Vaxart, Inc. (VXRT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
VXRT: Oral vaccine platform shows strong safety, broad pipeline, and major Sanofi partnership
A modular oral vaccine platform is advancing through late-stage trials for COVID-19, norovirus, and influenza, with strong safety and immunogenicity data and a major partnership with Sanofi. The oral pill format addresse
NEWS | Sep 14, 2026, 10:45 PM UTC
L
Vaxart adopts director resignation and stock ownership policies
Vaxart approved a Director Resignation Policy requiring directors who receive more withhold than for votes to promptly offer to resign and a Director Stock Ownership Policy setting a 2x cash retainer ownership target for
REGULATION | Sep 14, 2026, 08:17 PM UTC
L
Vaxart expands IP portfolio with European patent protection
Vaxart expanded its intellectual property portfolio with a European patent protecting proprietary norovirus vaccine technology.
EQUITY | Aug 26, 2026, 08:09 PM UTC